Live from Adopt AI - Grand Palais, this Deep Talk episode brings together Gautier Cloix, CEO of H-Company and Julie Huguet, Director of La French Tech. Cloix explains computer use, the technology behind H-Company's AI agents and why it removes the integration barrier that has slowed enterprise AI adoption. Huguet details how La French Tech’s Next40/120 programme helps high potential companies scale internationally, from fundraising to landing major clients.

Together, they discuss return on investment as the real test for any AI deployment, the balance between European sovereignty and global competitiveness and H-Company's plan to expand into North America, Asia, the Gulf region and Europe at the same time in 2026.

A conversation about what it actually takes to move AI from demonstration to daily use.

Hosted on Ausha. See ausha.co/privacy-policy for more information.

In this episode of Adopt AI Talks, recorded live at the Adopt AI - Grand Palais summit in Paris, host Anca Petre of Tech Anatomy sits down with Reda Guiha, Country President France at Pfizer, to explore how AI is reshaping health from the inside of one of the world's largest pharmaceutical companies.

Reda Guiha describes a renaissance in how health is researched, delivered and followed over time. He explains why Pfizer sees itself as a builder of the ecosystem, bridging academia, startups, biotechs and the public sector, and why partnerships are, in his words, the company's lifeblood.

The conversation moves through concrete results. A 25 to 30% efficiency gain across the preclinical portfolio. Around $735 million in AI improvements in 2025, on a path toward roughly $2 billion across the value chain. AI-powered diagnostics built with BioQuantus for a rare condition often misdiagnosed as heart failure. And a clinical trial success rate lifted from around 7% to 24%.

Anca Petre and Reda Guiha also discuss the shift from reactive to proactive and predictive health, the two factors behind Pfizer's most successful use cases, and direct advice for founders who want to partner with a global pharmaceutical leader.

A practical look at what AI in health already delivers, and what it will take to scale it.

Hosted on Ausha. See ausha.co/privacy-policy for more information.

"The quality of your AI output is only as good as the data behind it. And in banking, that is not a technical detail. It is a matter of trust."

At the Adopt AI Summit in Paris, Su Yang, Head of Artificial Intelligence & IT Innovation at BNP Paribas, joins Aldrick Zappellini, Group Data & AI Director & CDO at Crédit Agricole, moderated by YUNIK CEO Rémi Tibi, to deliver a grounded perspective on what it actually takes to industrialize generative AI in financial services. While the global conversation accelerates around agents, large language models and deployment speed, is the future of AI in banking actually dependent on solving a much more fundamental challenge first?

From 800 use cases in production and federated data architectures to dedicated AI adoption frameworks and retrieval-augmented generation quality controls, discover why scaling AI in finance depends entirely on getting data governance, human trust and organizational design right before anything else.

Hosted on Ausha. See ausha.co/privacy-policy for more information.